Dodecanoate
CAS 143-07-7
Dodecanoate (CAS 143-07-7) is a pharmaceutical compound with 5 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 30611.479166666668 nM | 19 | - |
| - | MIC | 600 ug.mL-1 | 17 | - |
| - | EC50 | 7861.011 nM | 10 | - |
| - | IC50 | 25990.523999999998 nM | 4 | - |
| - | Ki | 2170 nM | 1 | - |
| - | MIC | 62500 nM | 1 | - |
| Peroxisome proliferator-activated receptor alpha Nuclear hormone receptor |
IC50 | 4.52 | - | Homo sapiens |
| Peroxisome proliferator-activated receptor gamma Nuclear hormone receptor |
IC50 | 4.52 | - | Homo sapiens |
| Peroxisome proliferator-activated receptor delta Nuclear hormone receptor |
IC50 | 4.52 | - | Homo sapiens |
| Free fatty acid receptor 1 GPCR |
EC50 | 6.12 | - | Homo sapiens |
| G-protein coupled receptor 84 GPCR |
EC50 | 5.05 | - | Homo sapiens |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| GPR84 GPR84 |
Agonist | 5.05 pEC50 | 16966319 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| LAURIC ACID | 1363435 | SU | MTHSPL |
| Lauric Acid | 1363435 | SU | MTHSPL |
| lauric acid | 1363435 | SU | MTHSPL |
| lauric acid | 1363435 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Dodecanoate used for in pharmaceutical contexts?
Dodecanoate (CAS 143-07-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Dodecanoate?
No adverse-event association or SIDER side-effect rows are rendered for Dodecanoate in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Dodecanoate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Lauric Acid with EU status "permitted".
What clinical phase is Dodecanoate in?
No phase 1-4 clinical development badge is rendered for Dodecanoate because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Dodecanoate?
Dodecanoate has 11 bioactivity rows in this page query. Rendered target entries include Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor gamma, Peroxisome proliferator-activated receptor delta, Free fatty acid receptor 1, G-protein coupled receptor 84.